$77.56
$0.00 (0.00%)
End-of-day quote: 05/17/2024
NasdaqGS:BMRN
BioMarin Pharmaceutical Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| NOVO B | Novo Nordisk A/S | CPSE | Outperform | kr903.30 | kr696.07 | 0.00% | 14 | kr4.01T |
| PFE | Pfizer | NYSE | Outperform | $28.64 | $32.87 | 0.00% | 6 | $162.29B |
| SAN | Sanofi | ENXTPA | Outperform | 89.17€ | 102.80€ | 0.00% | 9 | 111.47€B |
| CSL | CSL | ASX | Outperform | $280.00 | $205.51 | 0.00% | 5 | $135.31B |
| 4568 | Daiichi Sankyo Company | TSE | Buy | ¥5.53k | ¥5.24k | 0.00% | 0 | ¥10.60T |
| MRNA | Moderna | NasdaqGS | Outperform | $132.90 | $135.42 | 0.00% | 1 | $50.93B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.13k | ¥4.74k | 0.00% | 0 | ¥6.48T |
| BIIB | Biogen | NasdaqGS | Outperform | $230.57 | $299.62 | 0.00% | 13 | $33.57B |
| BAYN | Bayer | XTRA | Hold | 28.58€ | 45.15€ | 0.00% | 4 | 28.08€B |
| ALNY | Alnylam Pharmaceuticals Inc | NASDAQ | Outperform | $149.40 | $245.24 | 0.00% | 7 | $18.90B |
| SRPT | Sarepta Therapeutics | NasdaqGS | Outperform | $131.38 | $158.66 | 0.00% | 6 | $12.51B |
| SOBI | Swedish Orphan Biovitrum AB (p... | OM | Outperform | kr277.00 | kr293.00 | 0.00% | 6 | kr96.39B |
| GRF | Grifols | BME | Outperform | 9.89€ | 18.48€ | 0.00% | 3 | 5.85€B |
| IONS | Ionis Pharmaceuticals | NasdaqGS | Outperform | $37.31 | $55.60 | 0.00% | 3 | $5.76B |
| NTLA | Intellia Therapeutics | NasdaqGM | Outperform | $26.22 | $75.84 | 0.00% | 21 | $2.36B |
| DYN | Dyne Therapeutics | NasdaqGS | Buy | $27.68 | $28.13 | 0.00% | 0 | $2.27B |
| DCPH | Deciphera Pharmaceuticals | NasdaqGS | Hold | $25.46 | $23.40 | 0.00% | 4 | $2.19B |
| 4516 | Nippon Shinyaku | TSE | Outperform | ¥3.70k | ¥8.34k | 0.00% | 0 | ¥261.33B |
| BCRX | BioCryst Pharmaceuticals | NasdaqGS | Outperform | $6.28 | $14.09 | 0.00% | 2 | $1.09B |
| WVE | Wave Life Sciences | NasdaqGM | Outperform | $6.26 | $9.21 | 0.00% | 3 | $688.23M |
| PHARM | Pharming Group N.V. | ENXTAM | Buy | 0.85€ | 1.85€ | 0.00% | 2 | 591.95€M |
| STOK | Stoke Therapeutics | NasdaqGS | Buy | $13.90 | $19.33 | 0.00% | 3 | $604.59M |
| ABUS | Arbutus Biopharma | NasdaqGS | Outperform | $2.98 | $6.34 | 0.00% | 0 | $535.96M |
| KALV | KalVista Pharmaceuticals | NasdaqGM | Buy | $11.92 | $20.80 | 0.00% | 0 | $478.84M |
| FULC | Fulcrum Therapeutics | NasdaqGM | Outperform | $7.55 | $10.21 | 0.00% | 7 | $456.83M |
| PYC | PYC Therapeutics | ASX | Buy | $0.10 | $0.30 | 0.00% | 1 | $294.90M |
